Free Trial
ASX:MDC

Medlab Clinical (MDC) Stock Price, News & Analysis

Medlab Clinical logo

About Medlab Clinical Stock (ASX:MDC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
A$15.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Medlab Clinical to be Delisted from ASX
Why Elon is funding the “Quantum Power Grid”
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year.
Medlab Clinical Faces Steep Revenue Decline and Loss
Child Care on College Campuses: What to Know
Clinical Laboratory Technician Salary
See More Headlines

MDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Construction
Current Symbol
ASX:MDC
CIK
N/A
Fax
N/A
Employees
1,640
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$3.94 million
Net Margins
-1,351.41%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
-A$1.47 million
Price / Cash Flow
5.12
Book Value
A($0.31) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$15.07 million
Optionable
Not Optionable
Beta
0.89
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:MDC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners